Monsanto to Acquire Rest
Of Calgene for $8 a Share

ST. LOUIS -- Monsanto Co. signed a definitive contract with Calgene Inc. to acquire the remaining Calgene shares it doesn't already own for $8 a share, or about $240 million.

Monsanto, an agricultural and biotechnology company, currently owns 36.4 million Calgene common shares, or about 55% of the outstanding Calgene shares. Calgene, based in Davis, Calif., introduced the Flavr Savr genetically altered tomato in 1994.